Collegium Pharmaceutical Inc (COLL)

[floblu14]

Collegium Pharmaceutical (COLL) Received its Third Buy in a Row
April 14 2022 - 05:45AM

After William Blair and H.C. Wainwright gave Collegium Pharmaceutical (NASDAQ: COLL) a Buy rating last month, the company received another Buy, this time from Needham. Analyst Serge Belanger maintained a Buy rating on Collegium Pharmaceutical today and set a price target of $36.00. The company's shares closed last Wednesday at $19.51. According to TipRanks.com, Belanger is a 4-star analyst with an average return of 6.2% and a 46.6% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Clarus Therapeutics Holdings, Amphastar Pharmaceuticals, and KalVista Pharmaceuticals. Collegium Pharmaceutical has an analyst consensus of Strong Buy, with a price target consensus of $28.00, which is a 45.

https://www.tipranks.com/news/blurbs/collegium-pharmaceutical-coll-received-its-third-buy-in-a-row-2?utm_source=advfn.com&utm_medium=referral